Efforts to develop new, more sensitive screening tests are thus likely to do more harm than good, as they increase the rate of over-diagnosis, without improving outcomes among women with aggressive cancers. What breast-cancer patients really need are tests that identify the risk that the disease actually poses, as well as new, lifesaving treatments.
因此研发新的、敏锐度更高的试验可能弊大于利，因为它们提高了过度诊断率，却无法为患有攻击型癌症的女性带来更多帮助。乳腺癌患者真正需要的是明确疾病实际风险的测试，以及能够挽救生命的新的治疗手段。是时候承认乳腺癌筛查不能挽救生命——并把注意力转移到能挽救生命的策略上来。